Several activist organisations will have to hand up communications with the Environmental Defenders Office over its unsuccessful challenge to the construction of a pipeline for Santos’ $5.6 billion Barossa gas project, as the energy giant mulls third-party costs orders against them.
Fashion retailer Mosaic Brands has flagged various COVID-related defences to a case brought by the Australian Competition and Consumer Commission alleging it failed to deliver several hundred thousand products to customers within advertised time frames.
A judge hearing the Victorian government’s bid to knock out a class action over its decision to retire Melbourne’s high-rise public housing towers has questioned the state’s submission that the decision had “no effect” on the rights of tenants.
A judge has found that a law firm failed in its duty to provide ongoing costs disclosures, in a fight over a legal bill that was double the size of the last estimate provided, rejecting an argument that the client should have understood the charges would climb.
Gordon Legal is investigating a possible class action related to alleged misconduct by a late Melbourne lawyer on behalf of people who provided “large sums of money” to him and his suburban legal practice.
Two employment silks and a criminal barrister have been selected by the NSW government to serve on the state’s restored Industrial Court.
As the head of Maurice Blackburn’s class actions group he helped win hundreds of millions of dollars for claimants and shaped the jurisprudence around the practice. As the Victorian Supreme Court’s newest judge, Andrew Watson has promised to keep up the fight for fair.
A class action targeting Victoria Police over its use of capsicum spray against protesters has lost its bid to uncover confidential information about police crowd control tactics, after a judge found disclosure of the information could “endanger the public”.
After a seven-year legal battle, a court has upheld the validity of Neurim Pharmaceutical’s patent for insomnia drug Circadin and ruled two generic drug companies infringed the intellectual property.
The High Court is set to weigh in on a challenge to a precedent-setting decision that found breaches of statutory duty under a provision of the Design and Building Practitioners Act are not apportionable, in a case with significant ramifications for the NSW construction industry.